Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1001-1004

  Vincenti, F ^a,c   Tuncer, M ^b   Castagneto, M ^b   Klinger, M ^b   Friman, S ^b   Scheuermann, E H ^b   Wiecek, A ^b   Russ, G R ^b   Martinek, A ^b   Nonnast Daniel, B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIRECT Study Group

^c Kidney Transplant Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; CAUSE OF DEATH; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIET RESTRICTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INTOXICATION; DRUG SAFETY; ETHNOLOGY; FEMALE; GLUCOSE METABOLISM; GRAFT FAILURE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INJURY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MICROEMULSION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SIDE EFFECT; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION;

EID: 17844385090     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.017     Document Type: Conference Paper

References (9)

1. S. Hariharan, C.P. Johnson, B.A. Bresnahan Improved graft survival after renal transplantation in the United States, 1988-1996 N Engl J Med 342 2000 605
2. D. Kavanagh, S.T.W. Morris, D.B. Northridge Electrocardiogram and outcome following renal transplantation Nephron 81 1999 109
3. A.O. Ojo, A.B. Leichtman, J.D. Punch Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes Am J Kidney Dis 36 2000 153
4. B.L. Kasiske, H.A. Chakkera, J. Roel Explained and unexplained ischemic heart disease risk after renal transplantation J Am Soc Nephrol 11 2000 1735
5. B.L. Kasiske, J.J. Synder, D. Gilbertson Diabetes mellitus after kidney transplantation in the United States Am J Transplant 3 2003 178
6. R.S. Woodward, M.A. Schnitzler, J. Baty Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients Am J Transplant 3 2003 590
7. J.D. Pirsch, J. Miller, M.H. Deierhoi A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantationFK506 Kidney Transplant Study Group Transplantation 63 1997 977
8. A.D. Mayer, J. Dmitrewski, J.P. Squifflet Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group Transplantation 64 1997 436
9. Margreiter R for the European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study Lancet 359 2002 741